Literature DB >> 3366689

Structure and biological activity of lipiarmycin B.

B Cavalleri1, A Arnone, E Di Modugno, G Nasini, B P Goldstein.   

Abstract

Actinoplanes deccanensis ATCC 21983, the producer of antibiotics lipiarmycin A3 and A4, furnished also a related antibiotic designated lipiarmycin B, active against Gram-positive bacteria, including anaerobes, and against Neisseria. The structures of the two major components, B3 and B4, were elucidated from their physico-chemical properties, 1H and 13C NMR spectra and fast atom bombardment mass spectra data in comparison with lipiarmycins A3 and A4.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3366689     DOI: 10.7164/antibiotics.41.308

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  6 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

Review 2.  Natural Products as Platforms To Overcome Antibiotic Resistance.

Authors:  Sean E Rossiter; Madison H Fletcher; William M Wuest
Journal:  Chem Rev       Date:  2017-09-27       Impact factor: 60.622

Review 3.  Actinomycetes: A Never-Ending Source of Bioactive Compounds-An Overview on Antibiotics Production.

Authors:  Davide De Simeis; Stefano Serra
Journal:  Antibiotics (Basel)       Date:  2021-04-22

4.  Fidaxomicin is an inhibitor of the initiation of bacterial RNA synthesis.

Authors:  Irina Artsimovitch; Jaime Seddon; Pamela Sears
Journal:  Clin Infect Dis       Date:  2012-08       Impact factor: 9.079

5.  Comparison of the safety, tolerability, and pharmacokinetics of fidaxomicin in healthy Japanese and caucasian subjects.

Authors:  Hiroyuki Oshima; Takao Yamazaki; Lauren Benner; Takashi Miki; Ingrid Michon; Tomasz Wojtkowski; Atsunori Kaibara; Salim Mujais
Journal:  Clin Drug Investig       Date:  2015-06       Impact factor: 2.859

6.  Final Demonstration of the Co-Identity of Lipiarmycin A3 and Tiacumicin B (Fidaxomicin) through Single Crystal X-ray Analysis.

Authors:  Stefano Serra; Luciana Malpezzi; Angelo Bedeschi; Claudio Fuganti; Piera Fonte
Journal:  Antibiotics (Basel)       Date:  2017-02-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.